Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers
Phase 1 Completed
31 enrolled 20 charts
Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors
Phase 1 Completed
18 enrolled
Retinoblastoma Biomarker Study
Completed
2,136 enrolled
AZD1775 in Treating Patients With Advanced Refractory Solid Tumors With CCNE1 Amplification
Phase 2 Completed
31 enrolled 13 charts
MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations
Phase 2 Completed
208 enrolled 27 charts
Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma
Phase 1 Completed
21 enrolled 19 charts
AZD1775 for Advanced Solid Tumors
Phase 1 Completed
67 enrolled 24 charts
Olaparib in People With Malignant Mesothelioma
Phase 2 Completed
23 enrolled 16 charts
Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations
Phase 1/2 Completed
9 enrolled 11 charts
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials
Completed
55 enrolled
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies
Phase 1 Completed
34 enrolled
SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
Phase 1/2 Completed
55 enrolled 22 charts
PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery
Phase 2 Completed
13 enrolled 7 charts
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
Phase 2 Completed
20 enrolled 12 charts
S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
Phase 2 Completed
54 enrolled 12 charts
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
Phase 1 Completed
53 enrolled
Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy
Phase 2 Completed
188 enrolled 11 charts
Smokefree.Gov Website in Helping United States Federal Employees Quit Smoking
Phase NA Completed
Immunotoxin Therapy in Treating Patients With Advanced Cancer
Phase 1 Completed
Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors
Phase 1 Completed
2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors
Phase 1 Completed
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene
Phase 1 Completed
Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy
Phase 1 Completed
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura
Phase 1 Completed
Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C
Completed
Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers
Phase NA Completed
28 enrolled
Bortezomib in Treating Children With Advanced Solid Tumors
Phase 1 Completed
36 enrolled
Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors
Phase 1 Completed
40 enrolled
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Phase 2 Completed
116 enrolled 8 charts
Pazopanib in Treating Patients With Malignant Pleural Mesothelioma
Phase 2 Completed
34 enrolled 10 charts
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
Phase 2 Completed
51 enrolled 5 charts
1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery
Phase 1 Completed
52 enrolled
1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors
Phase 1 Completed
27 enrolled
17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors
Phase 1 Completed
54 enrolled
Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma
Phase 2 Completed
39 enrolled 5 charts
Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
36 enrolled
Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors
Phase 1 Completed
26 enrolled
Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment
Phase 1 Completed
39 enrolled
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Phase 1 Completed
72 enrolled
R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
Phase 1 Completed
27 enrolled
Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies
Phase 1 Completed
28 enrolled
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
13 enrolled
SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery
Phase 1 Completed
39 enrolled
Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors
Phase 1 Completed
66 enrolled
Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
60 enrolled
Bevacizumab and Sunitinib in Treating Patients With Solid Tumors
Phase 1 Completed
60 enrolled
Aflibercept in Treating Young Patients With Relapsed or Refractory Solid Tumors
Phase 1 Completed
27 enrolled
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
Phase 2 Completed
106 enrolled